A bipartisan group of 31 senators last week urged Food and Drug Administration Commissioner Scott Gottlieb, M.D., to convene the Drug Shortages Task Force created by the FDA Safety and Innovation Act of 2012, stakeholders and other relevant agencies to report on the root causes of drug shortages and the authorities FDA and other federal agencies need to address them. “We appreciate the work of the agency to mitigate the impact of shortages created in the wake of Hurricane Maria and recent shortages resulting from manufacturing deficiencies,” the senators wrote. “However, drug shortages continue to present consistent, frequent, and significant risks for patients and threaten the stability of our health care system.” The letter was spearheaded by Senate Health, Education, Labor and Pensions Committee members Chris Murphy (D-CT) and Bill Cassidy (R-LA).
 

Related News Articles

Headline
Civica Rx, the not-for-profit generic drug company, officially opened its headquarters last week in Lehi, Utah.
Headline
The Food and Drug Administration Friday released draft guidance on how drug developers can apply for the agency’s Competitive Generic Therapies designation.
Headline
The AHA today submitted to the Food and Drug Administration legislative, regulatory and best practice recommendations to address new and chronic prescription…
Headline
The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists, and Institute for Safe…
Headline
The National Academies of Sciences, Engineering and Medicine has released a report summarizing its Sept. 5-6 workshop on medical drug shortages during…
Headline
The Food and Drug Administration will hold a public meeting Nov. 27 to receive stakeholder input on the underlying systemic causes of drug shortages and…